TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 102 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q1 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $402,000 | +6.9% | 130,920 | +119.5% | 0.35% | -26.1% |
| Q4 2017 | $376,000 | +22.1% | 59,646 | +32.5% | 0.47% | +1023.8% |
| Q3 2017 | $308,000 | +5.5% | 45,001 | +10.1% | 0.04% | -4.5% |
| Q2 2017 | $292,000 | +137.4% | 40,885 | +54.4% | 0.04% | -74.0% |
| Q1 2016 | $123,000 | – | 26,478 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 664,000 | $2,543,000 | 0.82% |
| GREAT POINT PARTNERS LLC | 452,375 | $1,733,000 | 0.44% |
| Clearline Capital LP | 267,915 | $1,026,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 300,000 | $1,149,000,000 | 0.18% |
| Rock Springs Capital Management LP | 662,500 | $2,537,000 | 0.16% |
| Eventide Asset Management | 600,000 | $2,298,000 | 0.14% |
| Granahan Investment Management | 657,496 | $2,518,000 | 0.08% |
| Candriam S.C.A. | 374,000 | $1,432,000 | 0.03% |
| Tekla Capital Management LLC | 192,322 | $737,000 | 0.03% |
| DOW CHEMICAL CO /DE/ | 65,000 | $249,000 | 0.02% |